Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

MS meditation, whether through mindfulness, breathwork, or guided walking, can help you manage the stress of living with the disease.

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

People exposed to PFAS and polychlorinated biphenyls (PCBs) are more likely to be diagnosed with multiple sclerosis (MS), a ...

The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to ...

Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

A new study has discovered a possible biomarker linked to multiple sclerosis disease progression that could help identify ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Last month, the FDA declined to approve Sanofi’s tolebrutinib for a specific form of multiple sclerosis. In a recently ...

Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson's disease and other neurodegenerative diseases today ...

NICE has recommended Tysabri and biosimilar Tyruko as an option for patients with highly active relapsing-remitting multiple ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...